Whole blood microsampling for the quantitation of ESTETROL (cas 15183-37-6) without derivatization by liquid chromatography-tandem mass spectrometry

Add time:08/04/2019    Source:sciencedirect.com

Quantitative bioanalysis and especially pharmacokinetic studies are challenging since only low volumes of biological material are available and low concentrations (ng/ml) are often expected. In this context, volumetric absorptive microsampling (VAMS) devices were developed to accurately collect 10 or 20 μl of whole blood from tested subjects. In this study, we present the development and validation of ultra-high performance liquid chromatography coupled to tandem mass spectrometry method after VAMS sampling for the quantitation of ESTETROL (cas 15183-37-6) (E4), a potentially new medicine for hormone replacement, contraception and osteoporosis therapies. Interestingly, a very simple sample preparation procedure was developed without any derivatization step. Even if lack of sensitivity is a common consideration when using negative ionization mode, we demonstrated in this work that an excellent sensitivity could be reached by carefully optimizing the nature and concentration of the mobile phase additive. After the optimization of every experimental parameter, the stability, selectivity, trueness, precision and accuracy of the final method were successfully demonstrated. In addition, the excellent performances of the method were confirmed by two independent proof-of-concept pharmacokinetic studies of E4 after VAMS collection in a murine model.

We also recommend Trading Suppliers and Manufacturers of ESTETROL (cas 15183-37-6). Pls Click Website Link as below: cas 15183-37-6 suppliers

Prev:Reduced hemostatic effects with drospirenone-based oral contraceptives containing ESTETROL (cas 15183-37-6) vs. ethinyl estradiol
Next:Ovulation inhibition by ESTETROL (cas 15183-37-6) in an in vivo model)